The IBC dilemma: Will Covid-19 relaxations render insolvency laws ineffective?
Anubha Agarwal| Policy Circle | 14-May-'20 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Too much of regulation may kill the spirit of CSR
Anubha Agarwal| Policy Circle | 02-Apr-'20 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Charmers for planet earth
Krishna Sarma| The Hindu | 20-Feb-'20 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why the Assamese are so angry with Citizenship Bill
Krishna Sarma| CNBC TV 18 | 13-Dec-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Assam Floods – Why 65 years of status quo?
Krishna Sarma| Financial Express| 20-Jul-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Competition law: Uncertain information exchange parameters will cut both ways
Jayakrishnan KR| Financial Express | 20-Sept-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Changes in insolvency laws: Homebuyers’ despair and government’s dilemma
Anubha Agarwal| Financial Express | 14-June-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why India needs to do much more on data privacy
Krishna Sarma| CNBC TV 18 | 23-Apr-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why Trump wants to end preferential trade treatment for India
Krishna Sarma| CNBC TV 18 | 06-Mar-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

The insolvency and bankruptcy code is not living up to its promise
Anubha Agarwal| CNBC TV 18 | 26-Feb-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

E-cigarettes: Regulation and not prohibition is the answer
Krishna Sarma| CNBC TV 18 | 15-Jan-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why biosimilars are a huge opportunity for the Indian biopharmaceutical industry
Krishna Sarma| CNBC TV 18 | 02-Jan-'19 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

MJ Akbar vs #MeToo Movement: How defamation cases play out in India
Krishna Sarma| CNBC TV18 | 17-Oct-'18 |

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Clinical Trials in India
Krishna Sarma & Manisha Singh | FDLI Update magazine | October/November 2018 issue

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why the one-woman director rule in companies is not enough for gender diversity
Anubha Agarwal | CNBC TV18 | 27-Aug-'18

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why the new arbitration bill is much ado about nothing
Krishna Sarma | CNBC TV18 | 16-Aug-'18

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Assam NRC Final Draft: A Démarche on the Way Forward is Essential
Krishna Sarma | The Quint | 01-Aug-'18

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

How sudden policy shifts are hurting development in the North-East
Krishna Sarma and Jayakrishnan KR | CNBC TV18 | 23-May-'18

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Monsanto ruling may hit innovation
Krishna Sarma | Hindu Business Line | 13-May-'18

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Of new drugs, safety and data exclusivity side effects
Krishna Sarma | Hindu Business Line | 18-Feb-'17

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Why cap prices of medical devices
Bhaskar Bhattacharya| The Financial Express | 18-Feb-'16

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Spurring R&D investment in medicine
Krishna Sarma | The Financial Express | 26-Nov-'15

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

The real test lies in proper testing
Krishna Sarma | Hindustan Times | 07-July-'14 (Biosims)

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Raising the bar too high
Krishna Sarma | Financial Express | 3-Apr-'13

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Guidelines on Similar Biologics- a milestone for India
Rajashree Sharma | Pharmabiz | 4-Oct-'12

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Is Sobering Tone On India IP Laws An Early Signal Of Reconciliation By U.S.?
CLG | Elsevier Business Intelligence (PharmAsia) | 2-May-'12

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Insider Analysis From Corporate Law Group New Delhi On India’s Drug Pricing Regulations
Krishna Sarma, Bhaskar Bhattacharya | Elsevier Business Intelligence (PharmAsia)| 23-Apr-'12

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Food and Nutraceutical Regulations - Global Snapshot
Rajashree Sharma | FnBnews.com | 3-Jan-'12

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Food and Nutraceutical Regulations - Global Snapshot
Rajashree Sharma, FnBnews.com, 3-Jan-'12

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Change of management, infusion of capital and concession should happen in a time-bound manner
Avijit Roy, India Business Law Journal, Jan, 2012

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Adjudication under the Food Safety and Standards Act, 2006
Minakshi Sarma Dabas, FnBnews.com, 26-Dec-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Regulatory approval procedure for biotech products
Rajashree Sharma, Pharmabiz, 20-Oct-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Sharing accountability for SAEs
Riku Sarma & Manisha Singh, Express Pharma, 5-Aug-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Indian nutraceuticals market – The road ahead
Rajashree Sharma, FnBnews, 30-Jun-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

New Food Regulatory Regime – Changes, Challenges and Way Ahead
Minakshi Sharma Dabas, The Centre for Science and Environment (CSE) newsletter, 21-Jun-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

CDSCO guidance Document on grant of licence for drugs import for test purposes
Manisha Singh, Chronicle Pharmabiz, 9-Jun-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Watch your health food basket
Rajashree Sharma, The Hindu Business Line, 13-May-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Free food body of corporate influence
Minakshi Sarma Dabas, Down To Earth, 15-Mar-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

India poised to be major global biotech player
Rajashree Sharma, Pharmabiz, 17-Feb-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Stem cell research & regulatory framework
Rajashree Sharma, Pharmabiz, 27-Jan-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

SMEs can benefit from use of IPRs- IPR Expert Explains How!
Krishna Sarma, The New Indian Express, 4-Jan-'11

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Competition law and trade associations
Krishna Sarma, The Financial Express, 30-Dec-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Public Funded Research In India: A Reckoner On Recent Legislative Actions
Rajashree Sharma, les Nouvelles-Journal of the Licensing Executives Society International (LESI), Dec 2010 issue

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Economics of biodiversity
Rajashree Sharma, The Financial Express, 17-Dec-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

India, a potential market for budding biosimilar cos
Rajashree Sharma, Pharmabiz.com, 25-Nov-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Regulation to fuel biosimilars boom
Rajashree Sharma, The Economic Times, 18-Nov-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

How to ride the biosimilar wave
Rajashree Sharma, The Financial Express, 8-Nov-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

International standard RDP will provide the correct incentives to innovate
Krishna Sarma, Express Pharma, 15-Sep-'10

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Indian companies gain, NOT just MNCs
Krishna Sarma, The Economic Times, 6-Jan-'09

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Dams of North-East raise crucial concerns
Krishna Sarma, The Economic Times, 28-Aug-'08

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Indian companies also gain tremendously - not just MNCs
Krishna Sarma, The Economic Times, 6-Jan-'09

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Patent linkage to drug regulation will enhance R&D efficiency
Krishna Sarma, The Economic Times, 13-May-'08

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Give fiscal support to brownfield airport projects
Jayakrishnan, The Economic Times, 18-Feb-'08

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Environmental Degradation and its Protection - Legal Perspectives
Avijit Roy, LegalServiceIndia.com, 1-Feb-'08

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Unleash shackles on Import of Remanufactured Capital Goods
Jayakrishnan, The Hindu Business Line, 5-Sep-'07

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

A Worrying Precedent - India Business Law
Ms. Krishna Sarma, Indian Business Law, 1-Sep-'07

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Trivial change may result in significant inventions
Krishna Sarma, The Economic Times, 8-May-'07

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin

Sequential' opposition delaying drug patents
Krishna Sarma, The Hindu Business Line, 3-Apr-'06

Share

Share on facebook

Share on google

Share on twitter

Share on linkedin